Brain Hypoxia develops when our brain receives less oxygen than required. Among the vast amount of cells in our body, the brain cells are most sensitive to oxygen deprivation. Five minutes without oxygen is enough for brain cells to start dying. Brain Hypoxia that lasts for five minutes or longer can cause seizures, coma or even brain death. Diminished oxygen supply to the brain may produce significant cognitive, physical and emotional impairments. As a result, a hypoxic injury can have a huge impact, in terms of functional Representing. Only 2-3% of an adult’s total body mass, the brain receives 20% of the cardiac output and accounts for about 25% of the body’s overall resting oxygen consumption. The brain is one of the most oxygen-sensitive organs of the body, and it is not surprising that neurologic dysfunction is a prominent manifestation of hypoxia.
Brain Hypoxia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Brain Hypoxia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2373 products for the study of Brain Hypoxia that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Brain Hypoxia is also known as Cerebral Hypoxia, Hypoxia Of Brain, Hypoxia, Brain, Hypoxia, Cerebral.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.